V116 is designed to target 21 serotypes that account for 85% of all invasive pneumococcal diseases in individuals aged 65 and over in the United StatesRead more...
V591 SARS-CoV-2 Vaccine
V591 SARS-CoV-2 vaccine candidate uses a measles virus vector platform to deliver the antigens to the immune system to spur antibody production against SARS-CoV-2Read more...
Valneva COVID-19 Vaccine
Valneva COVID-19 vaccine (VLA2001) consists of inactivated whole virus particles of SARS-CoV-2.Read more...
Vaqta Hepatitis A Vaccine
Vaqta is an inactivated whole virus vaccine derived from hepatitis A virus grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain.Read more...
Varivax Varicella Vaccine
Varivax is a live, attenuated varicella-zoster vaccine, a weakened form of the chickenpox virus.Read more...
VAX-24 Pneumococcal Conjugate Vaccine
Vaxcyte Inc. VAX-24 Pneumococcal Conjugate Vaccine candidate addresses infection from 24 serotypes of pneumococcal disease.Read more...
Vaxart COVID-19 Oral Vaccine
Vaxart oral COVID-19 VXA-CoV2-1 is an oral tablet vaccine targeting both the spike protein (S) and nucleoprotein (N) of the novel SARS-CoV-2 coronavirus.Read more...
Vaxart Norovirus Oral Vaccine
Vaxart’s oral norovirus vaccine candidate GI.1/GII.4 VXA-G1.1-NN consists of both Monovalent GII.4 VXA-G2.4-NS and Monovalent GI.1 VXA-G1.1-NN. Read more...
Vaxchora Cholera Vaccine (CVD 103-HgR)
Vaxchora (CVD 103-HgR) is a live, weakened cholera vaccine.
Vaxelis is a hexavalent (six-in-one) combination pediatric vaccine that includes antigens for diphtheria, tetanus, pertussis, and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...
VAXNEUVANCE 15 Pneumococcal Vaccine
VAXNEUVANCE Pneumococcal Vaccine (v114) consists of pneumococcal polysaccharides from 15 serotypes conjugated to a CRM197 carrier protein and includes serotypes 22F and 33FRead more...
Vaxzevria COVID-19 Vaccine (AstraZeneca)
Vaxzevria AstraZeneca COVID-19 Vaccine (AZD1222) consists of the replication-deficient simian adenovirus vector ChAdOx1.Read more...
VBI-1901 Glioblastoma Cancer Vaccine
VBI-1901 is a cancer vaccine that VBI Vaccines has designed to treat glioblastoma multiforme and medulloblastoma.Read more...
VBI-2601 Hepatitis B Vaccine
VBI-2601 (BRII-179) is a hepatitis therapeutic vaccine candidate that targets B- and T-cell immunity.Read more...
VC2 HSV Vaccine
Rational Vaccines VC2 vaccine candidate is a live-attenuated, engineered version of HSV-1. Read more...
Veklury (Remdesivir) Antiviral
Veklury (Remdesivir, DESREM, GS-5734, Redyx) is a nucleotide analog.Read more...
VGX-3100 HPV Cancer Vaccine
INOVIO VGX-3100 is an investigational immunotherapy vaccine.Read more...
VidPrevtyn Beta COVID-19 Vaccine
Vidprevtyn is a protein-based adjuvanted vaccine produced by Sanofi-GSK.Read more...
VIR-1111 HIV Vaccine
VIR-1111 HIV vaccine canidate is based on human cytomegalovirus that has been designed to elicit abundant T cells that recognize HIV epitopes in a way that differs from prior HIV vaccines.Read more...
VIR-2482 Influenza Monoclonal Antibody
VIR-2482 is an investigational prophylactic monoclonal antibody designed to protect against seasonal and pandemic influenza A.Read more...
Vitagerpavac Herpesvirus Vaccine
Vitagerpavac is a multivalent vaccine for the treatment of chronic herpesvirus infection (HCV) of types I and II currently available in Russia.Read more...
Vivotif Typhoid Vaccine
Vivotif Oral contains live bacteria called Salmonella typhi strain Ty21a, which do not cause typhoid fever.Read more...
VLA1601 Zika Vaccine
Valneva's VLA1601 Zika virus vaccine candidate development program is on hold.Read more...
VPM1002 Tuberculosis Vaccine
VPM1002 is a genetically modified BCG vaccine derived from the Mycobacterium bovis BCG subtype Prague characterized as rBCGÄureC::Hly+. Read more...
VRC5283 Zika Virus Vaccine
VRC5283 is a Zika Virus DNA Vaccine candidate.Read more...
VTP-500 MERS Vaccine
VTP-500 (ChAdOx1) MERS vaccine candidate treats MERS-CoV coronavirus.Read more...
Vyrologix (Leronlimab) Antibody
Vyrologix (Leronlimab) is a CCR5 antagonist with multiple therapeutic indications, including cancer, COVID-19, HIV, and cancer.Read more...
